Last:
Change: Change(%):
Volume: Open:
High: Low:
52Wk High: 52Wk Low:

MabVax is a clinical-stage biotechnology company with a fully human antibody discovery platform focused on the rapid translation into clinical development of products to address unmet medical needs in the treatment of cancer.